FinTrust Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.17M | Sell |
|
|||||
|
2024
Q2 | $2.09M | Sell |
|
|||||
|
2024
Q1 | $1.95M | Sell |
|
|||||
|
2023
Q4 | $1.83M | Buy |
|
|||||
|
2023
Q3 | $1.59M | Sell |
|
|||||
|
2023
Q2 | $1.45M | Buy |
|
|||||
|
2023
Q1 | $1.33M | Hold |
|
|||||
|
2022
Q4 | $1.28M | Sell |
|
|||||
|
2022
Q3 | $1.31M | Buy |
|
|||||
|
2022
Q2 | $1.05M | Sell |
|
|||||
|
2022
Q1 | $1.41M | Buy |
|
|||||
|
2021
Q4 | $389K | Sell |
|
|||||
|
2021
Q3 | $665K | Buy |
|
|||||
|
2021
Q2 | $154K | Buy |
|
|||||
|
2021
Q1 | $112K | Buy |
|
|||||
|
2020
Q4 | $36K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $13K | Hold |
|
|||||
|
2018
Q4 | $12K | Buy |
|